Zusammenfassung
Das kolorektale Karzinom ist weltweit eine der häufigsten malignen Erkrankungen, wobei die Inzidenz in den einzelnen Ländern der Erde sehr stark schwankt: Das Erkrankungsrisiko ist in Südafrika, Asien und Südamerika deutlich geringer als in den USA, Australien und Westeuropa. Für das Jahr 1998 wird die Zahl der in Deutschland neu an einem kolorektalen Karzinom Erkrankten auf 51.700 Menschen geschätzt (Kolonkarzinom: 34.346, Rektumkarzinom: 22.662). Dies entspricht einer Inzidenz für das Kolonkarzinom von etwa 34/100.000 bei Männern und von 27,4/1.000.000 bei Frauen. Beim Rektumkarzinom beträgt die geschätzte Inzidenz 26,9/100.000 für Männer und 16,7/100.000 für Frauen. Das Risiko, ein kolorektales Karzinom zu entwickeln, beträgt in der westlichen Welt bei Geburt 5,8–6,4%, das Risiko, daran zu versterben, 2,7–2,8%.
The erratum of this chapter is available at http://dx.doi.org/10.1007/978-3-662-06670-6_83
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aaltonen LA, Peltomaki P, Leach FS et al. (1993) Clues to the pathogenesis of familial colorectal cancer. Science 260: 812–816
Abulafi AM, Williams NS (1994) Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy. Br J Surg 81: 7–19
Adell G, Boeryd B, Franlund B, Sjödahl R, Hakansson (1996) Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes B colorectal carcinoma: an immunohistochemical study. Eur J Surg 162: 637–642
Adloff M, Arnaud JP, Bergamaschi R, Schloegel M (1989)Synchronous carcinoma of the colon and rectum: Prognostic and therapeutic implications. Am J Surg 157: 299–302.
Adson MA. Resection of liver metastases-when is it worthwhile? (1987) World J Surg 11:511–520
Advanced Colorectal Cancer Meta-Analysis Project (1992) Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate.J Clin Oncol 10: 896–903
Ahlquist DA, Wieand HS, Moertel CG et al. (1993) Accuracy of fetal occult blood screening for colorectal neoplasia. JAMA 269: 1262–1267
Akyol AM, McGregor JR, Galloway DJ, Murray GD, George WD (1991) Anastomotic leaks in colorectal cancer surgery:a risk factor for recurrence? Int J Colorect Dis 6: 179–183
Alden TD, Gianino JW, Saclarides TJ (1996) Brain metastases from colorectal cancer. Dis Colon Rectum 39: 541–545
Aldridge MC, Phillips RKS, Hittinger R, Fry JS, Fielding LP (1986) Influence of tumor site on presentation, management and subsequent outcome in large bowel cancer. Br J Surg 73: 663–670
Allen JI (1995) Molecular biology of colorectal cancer: a clinician’s view. Perspect Colon Rectal Surg 8: 181–202
Allgayer H, Heiss MM, Riesenberg R, Grützner KU, Tarabichi A, Babic R, Schildberg FW (1997) Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor disease. Cancer Res 57: 1394–1399
Allison JE, Tekawa IS, Ransom U, Adrian AL (1996) A comparison of fecal occult-blood tests for colorectal cancer screening. N Engl J Med 334: 155–159
Ardalan B, Chua L, Tian E et al. (1991) A phase Il study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma. J Clin Oncol 9: 625–630
Arenas RB, Fichera A, Mhoon D, Michelassi F (1997) Incidence and therapeutic implications of synchronous colonic pathology in colorectal adenocarcinoma. Surgery 122: 706–709
Armitage NC, Robins RA, Evans DF, Turner DC, Baldwin RW, Hardcastle JD (1985) The influence of tumor DNA abnormalities on survival in colorectal cancer. Br J Surg 72: 828–830
Arnold MW, Schneebaum S, Berens A, Mojzisik C, Hinkle G, Martin EW (1992) Radioimmunoguided surgery challenges traditional decision making in patients with primary colorectal cancer. Surgery 112: 624–630
Arvanitis ML, Jagelman DG, Fazio VW, Lavery IC, McGannon E (1990) Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 33: 639–642
Askew A, Ward M, Cowen A (1986) The influence of colonoscopy on the operative management of colorectal cancer. Med J Aust 145: 254–255
Astler VB, Coller FA (1954) The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 139: 846–852
Atkin WS, Morson BC, CuzickJ (1992) Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 326: 658–662
Atkin WS, Cuzick J, Northover JMA, Whynes DK (1996)Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 341: 736–740
August DA, Ottow RT, Sugarbaker PH (1984) Clinical perspective of human colorectal cancer metastasis. Cancer Met Rev 3: 303–324
Baba S (1997) Recent advances in molecular genetics of colorectal cancer. World J Surg 21: 678–687
Barnes JP (1952) Physiologic resection of the right colon.Surg Gynecol Ob-stet 94: 722–726
Beahrs OH, Sanfelippo PM (1971) Factors in prognosis of colon and rectal cancer. Cancer 9: 213–218
Beart RW, Melton LJ, Maruta M, Dockerty MB, Frydenberg HB, O’Fallon WM (1983)Trends in right and left sided colon cancer. Dis Colon Rectum 26: 393–398
Beart RW, O’Connell MJ (1983a) Postoperative follow-up of patients with carcinoma of the colon. Mayo Clin Proc 58: 361–363
Beart RW, Steele GD, Menck HR, Chmiel JS, Ocwieja KE, Winchester DP (1995) Management and survival of patients with adenocarcinoma of the colon and rectum:a national survey of the commission on cancer. J Am Coll Surg 181: 225–236
Becker K, Erckernbrecht JF, Haussinger D, Frieling T (1999) Cardiotoxicity of the antiproliferative compound fluorouracil. Drugs 57: 475–484
Behrens J, Jerchow BA, Wurtele M et al. (1998) Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280: 596–599
Bell SM, Scott N, Cross D et al. (1993) Prognostic value of p53 overexpression and c-ki-ras gene mutations in colorectal cancer.Gastroenterology 104: 57–64
Bengmark S, Hafström L (1969) The natural history of primary and secondary malignant tumors of the liver.I.The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 23: 198–202
Bengtsson G, Carlsson G, Hafström L, Jönsson PE (1981) Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 141: 586–589
Benhattar J, Losi L, Chaubert P, Givel JC, Costa J (1993) Prognostic significance of k-ras mutations in colorectal carcinoma. Gastroenterology 104: 1044–1048
Bernstein CN, Shanahan F, Weinstein WM (1994) Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 334: 71–74
Bertario L, Presciuttini S, Sala P, Rossetti C, Pietroiusti M (1994) Causes of death and postsurgical survival in familial adenomatous polyposis: re-suits from the Italian Registry.Semin Surg Oncol 10: 225–234
Bertsch DJ, Burak WE, Young DC, Arnold MW, Martin EW (1996) Radioimmunoguided surgery for colorectal cancer. Ann Surg Oncol 3: 310–316
Besbeas S, Stearns MW (1978) Osseous metastases from carcinomas of the colon and rectum. Dis Colon Rectum 21: 266–268
Best RR, Blair JB (1949) Sphincter preserving operations for rectal carcinoma as related to the anatomy of the Iymphatics.Ann Surg 130: 538–556
Biesalski HK (1997) Die Bedeutung der Ernährung in der Prävention und Therapie von Krebs. Dt Ärztebl 94: B-2827–2830
Bismuth H (1982) Surgical anatomy and anatomical surgery of the liver. World J Surg 6: 3–9
Bismuth H, Houssin D, Castaing D (1982) Major and minor segmentedtomies reglees in liver surgery. World J Surg 6: 10–24
Black WA, Waugh J (1948) The intramural extension of carcinoma ot the descending colon, sigmoid, and rectosigmoid: a pathologic study. Surg Gynecol Obstet 87: 457–464
Bleiberg H (1999) CPT-11 in gastrointestinal cancer. Eur J Cancer 35: 371–379
Bodmer WF, Bailey C, Bodmer J et al. (1987) Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328: 614–616
Bonnheim DC, Petrelli NJ, Herrera L, Walsh D, Mittelman A (1986) Osseous metastases from colorectal carcinoma. Am J Surg 151: 457–459
Bos JL (1989) Ras oncogenes in human cancer: a review. Cancer Res 49: 4682–4689
Bosari S, Viale G, Bossi P, Maggioni M, Coggi G, Murray JJ, Lee AK (1994) Cytoplasmic accumulation of p53 protein: an independent prognostic indicator of colorectal adenocarcinomas. J Natl Cancer Inst 86: 681–687
Braun S, Putz E, Pantel K (1995) ImmunzytochemischerTumorzellnachweis im Knochenmark–Indikationen und klinische Relevanz. In: Zeller WJ, zur Hausen H (Hrsg) Onkologie. Ecomed, Landsberg/Lech, S. 1–19
Brenner DE (1999) Cancer chemoprevention. Curr Opinion Gastroenterol 15: 9–15
Brierley JD, Cummings BJ, Wong CS, Keane Ti, O’Sullivan B, Catton CN, Goodman P (1995) Adenocarcinoma of the rectum treated by radical external radiation therapy.lnt J Radiat Oncol Biol Phys 31: 255–259
Bronner CE, Baker SM, Morrison PT et al. (1994) Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368: 258–261
Bruinvels DJ, Stiggelbout AM, Kievit J, van Houwelingen HC, Habbema DF, van de Velde CJH (1994) Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg 219: 174–182
Budach W, Belka C, Bamberg M (1998) Stellenwert der Radio- und Radiochemotherapie beim Rektumkarzinom.Onkologe 4 [Suppl 11: 40–48
Bueß G, Kayser J (1996) Technik und Indikation zur sphinctererhaltenden transanalen Resektion beim Rektumkarzinom.Chirurg 67: 121–128
Buhr HJ, Heuschen UA, Stern J, Herfarth Ch (1993) Kontinenzerhaltende Operation nach Proktocolektomie. Indikation, Technik und Ergebn i sse. C h i ru rg 64: 601–613
Bülow S (1987) Familial polyposis coli. Danish Medical Bulletin 34: 1–15
Bülow S (1989) Familial adenomatous polyposis. Ann Med 21: 299–307
Bundesärztekammer (1998) Richtlinien zur Diagnostik der genetischen Disposition für Krebserkrankungen. Dtsch Ärztebl 95: A1396–1403
Burchill SA, Bradbury ME, Pittman K, Southgate K, Smith B, Selby P (1995) Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 71: 278–281
Burke W, Petersen G, Lynch P et al. (1997) For the Cancer Genetics Studies Consortium. Recommendations for follow-up care of individuals with inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. J Am Med Assoc 277: 915–919
Burkitt DP (1971) Epidemiology of cancer of the colon and rectum. Cancer 28: 3–13
Busch E, Kemeny MM (1995) Colorectal cancer: Hepatic-directed therapy - the role of surgery, regional chemotherapy, and novel modalities. Semin Oncology 22: 494–508
Cady B, Stone MD (1991) The role of surgical resection of liver metastases in colorectal carcinoma. Semin Oncol 18: 399–406
Cahan WG, Castro EB, Hadju SI (1974) The significance of a solitary lung shadow in patients with colon carcinoma. Cancer 33: 414–421
Cali RL, Pitsch RM, Thorson AG, Watson P, Tapia P, Blatchford GJ, Christensen MA (1993) Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum 36: 388–393
Calle EE, Miracle-McMahill HL, Thun MJ, Heath CW (1995) Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women.J Natl Cancer Inst 87: 1067–1071
Campbell KA, Burns RC, Sitzmann JV, Lipsett PA, Grochow LB, Niederhuber JE (1993) Regional chemotherapy devices: effect of experience and anatomy on complications.J Clin Oncol 11: 822–826
Carlsson G, Petrelli NJ, Nava H, Herrera L, Mittelman A (1987) The value of colonoscopic surveillance after curative resection for colorectal cancer or synchronous adenomatous polyps. Arch Surg 122: 1261–1263
Carstensen JM, Bygren LO, Hatscheck T (1990)Cancer incidence among Swedish brewery workers.lnt J Cancer 45: 393–396
Carter R, Hemingway D, Cooke TG, Pickard R, Poon FW, McKillop JA, McArdle CS (1996) A prospective study of six methods for detection of hepatic colorectal metastases. Ann R Coll Surg Engl 78: 27–30
Caspari R, Olschwang S, Friedl W et al. (1995) Familial adenomatous polyposis: desmoid tumors and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 4: 337–340
Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM (1987) A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206: 685–693
Cho E, Ashihara T, Mizuma Y (1991) Endoscopic ultrasonography in the assessment of endoscopic resection for colorectal carcinoma. Gastrointest Endosc 37: 263–264
Choi PM, Nugent FW, Schoetz DJ, Silverman ML, Haggitt RC (1993) Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis.Gastroenterology 105: 418–424
Chung M, Steinmetz OK, Gordon PH (1993) Perioperative blood transfusion and outcome after resection for colorectal carcinoma. Br J Surg 80: 427–432
Cianchi F, Messerini L, Palomba A, Boddi V, Perigli G, Pucciani F, Bechi P, Cortesini C (1997) Character of the invasive margin in colorectal cancer. Dis Colon Rectum 40: 1170–1176
Cochrane JPS, Williams JT, Faber RG, Slack WW (1980) Value of outpatient follow-up after curative surgery for carcinoma of the large bowel. Br Med J 280: 593–595
Cohen AM, Minsky BD, Schilsky RL (1997) Cancer of the rectum. In: De Vita VT, Hellmann S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 5th ed. Lippincott-Raven, Philadelphia, pp 1206–1208
Cohen AM, Tremiterra S, Cancela F, Thaler HT, Sigurdson ER (1991) Prognosis of node-positive colon cancer. Cancer 67: 1859–1861
Connell WR, Lennard-Jones JE, Williams CB, Talbot IC, Price AB, Wilkinson KH (1994a) Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 107: 934–944
Connell WR, Sheffield JP, Kamm MA, Ritchie JK, Hawley PR, Lennard-Jones JE (1994b) Lower gastrointestinal malignancy in Crohn’s disease. Gut 35: 347–352
Correa P, Haenszel W (1978) The epidemiology of large bowel cancer. Adv Cancer Res 26: 1–141
Cosgrove JM, Wolff WI, Tenenbaum N, Margolis IB (1991) An appriasal of small and diminutive colonic polyps.Surg Endosc 5: 143–145
Culotta E, Koshland DE (1993) P53 sweeps through cancer research.Science 262: 1958–1961
Cunliffe WJ, Hasleton PS, Tweedle DE, Schofield PF (1984) Incidence of synchronous and metachronous colorectal carcinoms. Br J Surg 71: 941–943
Cunningham D, Pyrhönen S, James RD et al. (1998) A phase Ill multicenter randomized study of CPT-11 versus supportive care alone in patients with 5FU-resistant metastatic colorectal cancer. ASCO Proc. 17: 1
Cutait R, AIvesVAF, Lopes LC, Cutait DE, BorgesJLA, SingerJ, da Silva JH, Goffi FS (1991) Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 34: 917–920
Daly JM, Kemeny NE (1997) Metastatic cancer to the liver. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer, 5th edn. Lippincott-Raven, Philadelphia, pp 2551–2570
Dasmahapatra KS, Lopyan K (1989) Rationale for aggressive colonoscopy in patients with colorectal neoplasia. Arch Surg 124: 63–66
Gramont A, Figer A, Seymour M et al. (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.J Clin Oncol 18: 2938–2947
De Verdier MG, Plato N, Steinbeck G (1992) Occupational exposures and cancer of the colon and rectum. Am J Ind Med 22: 291–303
Deans GT, Parks TG, Rowlands BJ, Spence RAJ (1992) Prognostic factors in colorectal cancer. Br J Surg 79: 608–613
Deutsche Krebsgesellschaft (2002a) Kolonkarzinom. In: Kurzgefasste interdisziplinäre Leitlinien, 3. Aufl. W. Zuckschwerdt, München Bern Wien New York, S 160–171
Deutsche Krebsgesellschaft (2002b) Rektumkarzinom. In: Kurzgefasste interdisziplinäre Leitlinien, 3. Aufl. Zuckschwerdt, München Bern Wien New York, S 172–186
Devesa SS, Chow WH (1993) Variation in colorectal cancer incidence in the United States by subsite of origin.Cancer 71: 3819–3826
Doll R, Peto R (1981) The causes of cancer.) Natl Cancer Inst 66: 1191–1308
Douillard JY, Cunningham D, Roth AD et al. (2000) Irinotecan combined with fluorouracil alone as first line treatment for metastatic colorectal cancer:a multicentre randomised trial. Lancet 355: 1041–1047
Dukes CE (1932) The classification of cancer of the rectum.J Path Bact 35: 323–332
Dukes CE, Bussey Hi (1958) The spread of the rectal cancer and its effect on prognosis. Br J Cancer 12: 309–320
Düx M (1998) Hydrosonographie and Hydro-CT.Nachweis and Stadieneinteilung von kolorektalen Karzinomen. Onkologe 4 [Suppl 1]; S15 - S22
Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, Du Bois RN (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and carcinomas. Gastroenterology 107: 1183–1188
Eble MJ, Kallinowski F, Wannenmacher MF, Herfarth Ch (1994) Intraoperative Radiotherapie des lokal ausgedehnten and rezidivierten Rektu m ka rzi noms. C h i ru rg 65: 585–592
Eckardt VF, Bernhard G (1997) Nachsorge beim kolorektalen Karzinom. Dtsch Ärztebl 94: A456–462
EideTJ (1986)The age, sex and site specific occurence of adenomas and carcinomas of the large intestine within a defined population. Scand J Gastroenterol 21:1083–1088
EideTJ (1991) Natural history of adenomas. World J Surg 15: 3–6
Ekberg H, Tranberg KG, Andersson R, Lundstedt C, Hagerstrand I, Ranstam J, Bengmark S (1986) Determinants of survival in liver resection for colorectal secondaries. Br J Surg 73: 727–731
Ekbom A, Helmick C, Zack M, Adami HO (1990a) Ulcerative colitis and colorectal cancer: a population-based study. N Engl J Med 323: 1228–1233
Ekbom A, Helmick C, Zack M, Adami HO (1990b) Increased risk of large bowel cancer in Crohn’s disease with colonic involvement. Lancet 336: 357–359
Engell HC (1955) Cancer cells in the circulating blood.Acta Chir Scand 201 [Suppl]: 1–70
Engel) HC (1959) Cancer cells in the blood. A five to nine year follow up study. Ann Surg 149: 457–461
Evers BM, Mullins RJ, Mathews TH (1988) Multiple adenocarcinomas of the colon and rectum: an analysis of incidences and current trends. Dis Colon Rectum 31: 518–522
Fazeli A, Dickinson SL, Hermiston ML et al. (1997) Phenotype of mice lacking functional deleted in colorectal cancer ( DCC) gene. Nature 386: 796–804
Fearon ER, Cho KR, Nigro JM et al. (1990a) Characterisation of a chromosome 18 gene that is altered in colorectal cancer. Science 247: 49–56
Fearon ER, Vogelstein B (1990b) A genetic model for colorectal tumorigenesis. Cell 61: 759–767
Fenoglio CM, Kaye GI, Lane N (1973) Distribution of human colonic lymphatics in normal, hyperplastic and adenomatous tissue. Gastroenterology 64: 51–66
Finlay G, McArdle CS (1986) Occult hepatic metastases in colorectal carcinoma. Br J Surg 73: 732–735
Fishel R (1998) Mismatch repair, molecular switches, and signal transduction. Genes Dev 12: 2096–2101
Fishel R (2001) The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: revising the mutator hypothesis. Cancer Res 61: 7369–7374
Fishel R, Lescoe MK, Rao MRS et al. (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75: 1027–1038
Fisher B, Wolmark N, Rockette H et al. (1988) Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NS-ABP Protocol R-01.1 Ntl Cancer Inst 80: 21–29
Fisher ER, Turnbull RB (1955) The cytological demonstration and significance of tumor cells in the mesenteric venous blood in patients with colorectal carcinoma. Surg Gynecol Obstet 100: 102–108
Fitzgibbons RJ Jr, Lynch HT, Stanislav GV et al. (1987) Recognition and treatment of patients with hereditary non polyposis colorectal cancer (Lynch syndromes I and II).Ann Surg 206: 289–294
Flenzel-Beyme R (1991) 1st der vegetarische Lebensstil empfehlenswert für die Verringerung des Krebsrisikos und der Sterblichkeit am Herzinfarkt? Dtsch Zschr Onkol 23:145–154
Fodde R, Kuipers J, Rosenberg C et al. (2001) Mutations in the APC tumor suppressor gene cause chromosomal instability. Nat Cell Biol 3: 433438
Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4–6
Folkman J (1995)Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1:27–31
Frings S (1998) Capecitabine–a novel oral tumor-activated fluoropyrimidine.Onkologie 21: 451–458
Frühmorgen P (1996) Kolorektale Polypen und Polyposen.In:Hahn EG, Riemann JF (Hrsg) Klinische Gastroenterologie, 3. Aufl.Thieme, Stuttgart New York
Frykholm GJ, Glimelius B, Pahlman L (1993) Preoperative or postoperative irradiation in adenocarcinoma of the rectum:final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 36: 564–572
Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willet WC (1994) A prospective study of family history and the risk of colorectal cancer. N Engl J Med 331: 1669–1674
Fuchs CS, Giovannucci EL, Colditz GA et al. (1999) Dietary fiber and the risk of colorectal cancer and adenoma in women. N Eng J Med 340: 169–176
Fujita S, TeramotoT, Watanabe M, Kodaira S, Kitajima M (1993) Anastomotic leakage after colorectal cancer surgery:a risk factor for recurrence and poor prognosis.Jpn J Clin Oncol 23: 299–302
Funke I, Schraut W (1998) Meta-analysis of studies on bone marrow micrometastases:an independent prognostic impact remains to be substantiated.) Clin Oncol 16: 557–566
Gabriel WB, Dukes C, Bussey Hi (1935) Lymphatic spread in cancer of the rectum. Br J Surg 23: 395–413
Gann PH, Manson JE, GIyn RJ, Buring JE, Hennekens CH (1993) Low dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 85: 1220–1224
Gebert J, Dupon C, Kadmon M, Hahn M, Herfarth Ch, von Knebel Doeberitz M, Schackert HK (1999) Combined molecular and clinical approaches for the identification of families with familial adenomatous polyposis coli (FAP).Ann Surg 229: 350–361
Geoghegan JG, Scheele J (1999) Treatment of colorectal liver metastases. Br J Surg 86: 158–169
Gilbert JM, Jeffrey I, Evans M, Kark AE (1984) Sites of recurrent tumor after curative colorectal surgery: implications for adjuvant therapy. Br J Surg 71: 203–205
Giovannucci E (1995b) Insulin and colon cancer. Cancer Causes Control 6: 164–179
Giovannucci E, Stampfer M, Colditz GA et al. (1993) Folate, methionine and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 85: 875–884
Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1995a) Physical activity, obesity and risk for colon cancer and adenoma in men. Am Intern Med 122: 327–334
Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Kearney), Willett WC (1994a) A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. J Nat Cancer Inst 86: 183–191
Giovannucci E, Colditz GA, Rimm EB et al. (1994b) A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S.women.J Nat Cancer Inst 86: 192–199
Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC (1994c) Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 121: 241–246
GITSG (1992) Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum.J Clin Oncol 10: 549–557
Glaser F, Kuntz C, Schlag P, Herfarth Ch (1993) Endorectal ultrasound for control of preoperative radiotherapy of rectal cancer. Ann Surg 217: 64–71
Goh HS, YaoJ, Smith DR (1995) P53 point mutations and survival in colorectal cancer patients. Cancer Res 55: 5217–5221
Gold P (1996) The carcinoembryonic antigen (CEA): discovery and three decades of study. Perspect Colon Rectal Surg 9: 1–47
Grace RH, Hale M, Mackie G, Marks CG, Bloomberg TJ, Walker WJ (1987). Role of ultrasound in the diagnosis of liver metastases before surgery for large bowel cancer. Br J Surg 74: 480–481
Graham RA, Wang S, Catalano PJ, Haller DG (1998) Postsurgical surveillance of colon cancer. Ann Surg 228: 59–63
Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW (1994) Identification of occult micrometastases in pericolic lymph nodes of Dukes’ B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49.Cancer 73: 563–569
Greenwald P, Lanza E, Eddy GA (1987) Dietary fiber in the reduction of colon cancer risk.J Am Diet Assoc 87: 1178–1188
Gridley G, Mc Laughlin JK, Ekbom A et aí. (1993) Incidence of cancer among patients with rheumatoid arthritis.J Natl Cancer Inst 85: 307–311
Grinnell RS (1950) The spread of carcinoma of the colon and rectum.Cancer 3: 641–652
Grinnell RS(1996) Lymphatic block with atypical and retrograde lymphatic metastasis and spread in carcinoma of the colon and rectum. Ann Surg 163:272–280
Groden J, Thliveris A, Samowitz W et al. (1991) Identification and characterisation of the familial adenomatous polyposis coli gene. Cell 66: 589–600
Gunderson LL, Martin JK, Beart RW et al. (1988) Intraoperative and external beam irradiation for locally advanced cancer. Ann Surg 207: 52–60
Gunderson LL, Sosin H (1974) Areas of failure found at reoperation (second or symptomatic look) following„curative surgery” for adenocarcinoma of the rectum: clinicopathologic correlation and implications for adjuvant therapy. Cancer 34: 1278–1292
Gunn J, McCall JL, Yun K, Wright PA (1996) Detection of micrometastases in colorectal cancer patients by kl 9 and k20 reverse-transcription polymerase chain reaction. Lab Invest 75: 611–616
Gurbuz AK, Giardiello FM, Petersen GM et al. (1994) Desmoid tumours in familial adenomatous polyposis.Gut 35: 377–381
Gusterson B (1991) Are micrometastasis clinically relevant? Br J Hosp 47: 247–248
Haboudi NY, Clark P, Kaftan SM, Schofield PF (1992) The importance of combing xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma.J R Soc Med 85: 386–388
Hall NR, Bishop DT, Stephenson BM, Finan Pi (1996) Hereditary susceptibility to colorectal cancer. Relatives of early onset cases are particular at risk. Dis Colon Rectum 39: 739–743
Haller DG, Catalano PJ, Macdonald JS, Mayer RJ for ECOG, SWOG and CALGB (1996) Fluorouracil, leucovorin ans levamisole adjuvant therapy for colon cancer: preliminary results of INT-0089. ASCO Proc. 15: #486, p 211
Halvorsen TB, Johannesen E. DNA ploidy, tumor site, and prognosis in colorectal cancer (1990) A flow cytometric study of paraffin-embedded tissue.Scand J Gastroenterol 25: 141–148
Hamelin R, Laurent-Puig P, Olschwang Set al. (1994) Association of p53 mutations with short survival in colorectal cancer.Gastroenterology 106: 42–48
Hammoud MA, McCutcheon IE, Elsouki R, Schoppa D, Platt YZ (1996) Colorectal carcinoma and brain metastases: distribution, treatment and survival. Ann Surg Oncol 3: 453–463
Hara AK, Johnson CD, Reed JE, Ahlquist DA, Nelson H, Ehman RL, McCollough CH, Ilstrup DM (1996a). Detection of colorectal polyps by computed tomographic colography: feasibility of a novel technique. Gastroenterology 110: 284–290
Hara AK, Johnson CD, Reed JE, Ehman RL, Ilstrup DM (1996b) Colorectal polyp detection in CT colography: two- versus three-dimensional techniques.Work in progress. Radiology 200: 49–54
Hardcastle JD, Chamberlain JO, Robinson MH et al. (1996) Randomised controlled trial offaecal-occult-blood screening for colorectal cancer. Lancet 348: 1472–1477
Harris CC (1993) P53: at the crossroads of molecular carcinogenesis and risk assessment. Science 262: 1980–1981
Hase K, ShatneyC, Johnson D, Trollope M, Vierra M (1993) Prognostic value of tumor budding in patients with colorectal cancer. Dis Colon Cancer 36: 627–635
Hawes RH (1993) New staging techniques. Endoscopic ultrasound. Cancer 71: 4187–4192
Hawes RH, Wiersema MJ (1993) Role of endoscopy in the staging of colorectal carcinoma. Endoscopy 25: 101–107
Heald RJ, Husband EM, Ryall RDH (1982) The mesorectum in rectal cancer surgery–the clue to pelvic recurrence. Br J Surg 69: 613–616
Heald RJ, Ryall RDH (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 11: 1479–1482
Hecht JR (1997) Genetics, epidemiology, prevention, and early detection of colorectal cancer. Curr Opinion Gastroenterol 13: 5–10
Heinemann EF, Hoar Zahm S, Mc Laughlin JK, Vaught JB (1995) Increased risk of colorectal cancer among smokers:results ofa 26-year follow up of US veterans and a review. Int J Cancer 59: 728–738
Heiskanen I, Jarvinen Hi (1996) Occurrence ofdesmoid tumours in familial adenomatous polyposis and results of treatment. Int J Colorectal Dis 11: 157–162
Heiss MM, Allgayer H, Gruetzner KU, Funke I, Babic R, Jauch KW, Schildberg F (1995). Individual development and uPA-receptor expression of disseminated tumor cells in bone marrow: a reference to early systemic disease in solid cancer. Nat Med 1: 1035–1039
Herfarth Ch, Heuschen G, Heuschen UA (1998) Die maligne Entartung im Verlauf der Colitis ulcerosa und ihre chirurgischen Implikationen. Chirurg 69: 1020–1027
Herfarth Ch, Runkel N (1994) Chirurgische Standards beim primären Kolonkarzinom.Chirurg 65: 514–523
Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB(1995) Inactivation of the CDKN2/p16/MTS1 genesis frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55: 4525–4530
Hermanek P (1989) Chirurgische Pathologie der regionären Lymphknotenmetastasen und Fernmetastasen. In: Rothmund M (Hrsg). Metastasenchirurgie.Thieme, Stuttgart New York, S 17–22
Hermanek P (1992) Dysplasie-Karzinom-Sequenz im Kolorektum. Zentralbi Chir 117: 476–482
Hermanek P, Frühmorgen P, Guttenmoos-Holzmann I, Altendorf A, Matek W (1983) The malignant potential of colorectal polyps–a new statistical approach. Endoscopy 15: 16–20
Hermanek P, Wiebelt H, Riedl S, Staimmer D, Hermanek P und die Studiengruppe Kolorektales Karzinom (1994) Langzeitergebnisse der chirurgischen Therapie des Coloncarcinoms. Chirurg 65: 287–297
Hermanek P, Wiebelt H, Staimmer D, Riedl S and the German Study Group Colo-Rectal Carcinoma (1995) Prognostic factors of rectum carcinoma–experience of the German multicentre study SGCRC.Tumori 81 [Suppe]: 60–64
Herrera L, Villarreal JR (1992) Incidence of metastases from rectal adenocarcinoma in small lymph nodes detected by a clearing technique. Dis Colon Rectum 35: 783–788
Herrmann T (1999) Welche Rolle spielt die Strahlentherapie in derTherapie des Kolonkarzinoms? Onkologe 5: 35–38
Herrmann KA, Waggershauser T, Helmberger T, Heinemann V, Sittek H, Reiser M (1999) Percutaneous interventional radiologic implantation of intravenous port-catheter systems. Radiology 39: 777–782
Heuschen G, Heuschen UA, Herfarth Ch (1998a) Primär sklerosierende Cholangitis–Colitis-ulcerosa assoziierte Erkrankung mit chirurgischen Konsequenzen. Chirurg 69: 1028–1034
Heuschen UA, Heuschen G, Herfarth Ch (1998b) Lebensqualität nach Prok- tokolektomie wegen Colitits ulcerosa. Chirurg 69: 1045–1051
Heuschen UA, Heuschen G, Rudeck B, Hinz U, Stern J, Herfarth Ch (1998c) Lebensqualität im Langzeitverlauf nach kontinenzerhaltender Proktokolektomie wegen Colitis ulcerosa und familiärer adenomatöser Polyposis. Chirurg 69: 1052–1058
Hoff P (2000) Capecitabine as first-line treatment for colorectal cancer:Integrated results of 1207 patients from 2 randomized, phase Ill studies. Ann Oncol 11 [Suppl 4]: 60
Hohenberger P, Schlag PM, Gerneth T, Herfarth Ch (1994) Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Ann Surg 219: 135–143
Hohenberger W, Hermanek P, Hermanek P, Gall FP (1992) Decision-making in curative rectum carcinoma surgery.Onkologie 15: 209–220
Hohenberger W, Hermanek P, König HJ (1996) Kolon-, Rektum- und Analkanaltumoren. In: Hahn EG, Riemann JF (Hrsg) Klinische Gastroenterologie.Thieme, Stuttgart New York, S 991–1024
Hohn DC, Stagg RJ, Friedman MA et al. (1989) A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver:The Northern California Oncology Group Trial.J Clin Oncol 7: 1646–1654
Hojo K, Koyama Y, Moriya Y (1982) Lymphatic spread and its prognostic value in patients with rectal cancer. Am J Surg 144: 350–354
Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancer.Science 253: 49–53
Hama DM, Garabrand DH, Gillespie BW (1994) A meta-analysis of colorec- tal cancer and asbestos exposure. Am J Epidemiol 139: 1210–1212
Horn A, Dahl O, Morild I (1990) The role of venous and neural invasion on survival in rectal adenocarcinoma. Dis Colon Rectum 34: 798–804
Huges ES, McDermott FT, Polglase AI, Johnson WR (1983) Tumor recurrence in the abdominal wall scar tissue after large-bowel cancer surgery. Dis Colon Rectum 26: 571–572
Huges KS, Scheele J, Sugarbaker PH (1989) Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment. Surg Clin North Am 69: 339–359
Husmann DA, Spence HM (1990) Current status of tumor of the bowel following ureterosigmoidostomy:a review.J Urol 144: 607–610
lida M, Yao T, Itoh H, Watanabe H, Matsui T, Iwashita A, Fujishima M (1989) Natural history of duodenal lesions in Japanese patients with familial adenomatosis coli ( Gardner’s Syndrome ). Gastroenterology 96: 13011306
Ikeda M, Orimo H, Moriyama H et al. (1998) Close correlation between mutations of E2F4 and hMSH3 genes in colorectal cancers with microsatellite instability. Cancer Res 58: 594–598
Ilyas M, Tomlinson IP (1997) The interactions of APC, E-cadherin and betacatenin in tumor development and progression. J Pathol 182: 128–137
International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators (S. Marsoni) (1995) Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 345: 939–944
lwao K, Nakamori S, Kameyama M et al. (1998) Activation of the betacatenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res 58: 1021–1026
Iwatsuki S, Esquivel CO, Gordon RD, Starzl T (1986) Liver resection for metastatic colorectal cancer. Surgery 100: 804–810
Jackman RJ, Mayo CW (1951) The adenoma-carcinoma sequence in cancer of the colon. Surg Gynecol Obstet 93: 327–330
Jakob AR, Kühl M, Jauch KW, Schalhorn A, WilmannsW (1996) Complications using implantable port-systems for regional chemotherapy of liver metastases. Reg Cancer Treat 9: 33–36
Jass JR, Whitehall VU, Young J, Leggett BA (2002) Emerging concepts in colorectal neoplasia. Gastroenterology 123: 862–876
Jeffers MD, O’Dowd GM, Mulcahy H, Stagg M, O’Donoghue DR Toner M (1994) The prognostic significance of immunohistochemically detected lymph nodes micrometastases in colorectal carcinoma. J Pathol 172: 183–187
Jen J, Hoguen K, Piantadosi S et al. (1994) Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 331: 213–221
Jessup JM, McGinnis LS, Steele GD, Menck HR, Winchester DP (1996) The na- tional cancer data base report on colon cancer. Cancer 79: 918–926
Jiang W, Tillekertane MR Brattain MG, Banerji SS (1997) Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells. Biochemistry 36: 14786–14793
Jonker DJ, Maroun JA, Kocha W (2000) Survival benefit of chemotherapy ion metastatic colorectal cancer: a meta-analysis or randomized controlled trials. Br J Cancer 82: 1789–1794
Jorgensen T, Rafaelsen S (1992) Gallstones and colorectal cancer–there is a relationship, but it is hardly due to cholecystectomy. Dis Colon Rectum 35: 24–28
Juhl H, Stritzel M, Wroblewski A et al. (1994) Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer 57: 330–335
Kadmon M, Möslein G, Buhr HJ, Herfarth Ch (1995) Desmoide bei Patienten mit familiärer adnomatöser Polyposis (FAP). Klinische und therapeutische Beobachtungen des Heidelberger Polyposis Registers. Chirurg 66: 997–1005
Kadmon M, Timmermanns G, Buhr HJ, Herfarth Ch (1994) Das Rektumkarzinom bei familiärer adenomatöser Polyposis coli ( FAP ): Effiziente Prävention durch ileoanale Pouchanlage (IAP). Langenbecks Arch Chir Suppl (Kongressbericht(: 323–326
Kalgutkar AS, Crews BC, Rowlinson SW, Graner C, Seibert K, Marnett LJ (1998) Aspirin like molecules that covalentely inactivate cyclooxygenase-21211. Science 280: 1268–1270
Kapiteijn E, Marijnen CAM, Magtegaal I et al. (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345: 638–648
Kemeny N, DalyJ, Reichman B, Geller N, BotetJ, Oderman P (1987) Intrahepatic or systemic infusion of fluorodeoxy-uridine in patients with liver metastases from colorectal carcinoma. Ann Int Med 107: 459–465
Kemeny N, Seiter K, Niedzwiecki D et al. (1992) A randomized trial of intra-hepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 69: 327–334
Kern W, Beckert B, Lang N et al. (2001) Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer. Ann Oncol 12: 599–603
Keynes KM (1961) Implantation from the bowel lumen in cancer of the large intestine. Ann Surg 153: 357–364
Kienle R Stern J, Herfarth Ch (1996) Restaurative Proktektomie, Kontinuitätswiederherstellung mit und ohne Colon-J-Pouch. Langenbecks Arch Chir Suppl II: 262–264
Killingback M, Wilson E, Huges ESR (1965) Anal metastases from carcinoma of the rectum and colon. Aust N Z J Surg 34: 178–187
Kinzler KW, Nilbert MC, Su L-K et al. (1991) Identification of FAP locus genes from chromosome 5g21. Science 253: 661–665
Kinzler KW, Vogelstein B (1997) Gatekeepers and caretakers. Nature 386: 761–763
Klemmer S, Pascoe L, DeCosse J (1987) Occurrence of desmoids in patients with familial adenomatous polyposis of the colon.Am J Med Genet 28: 385–392
Köckerling F, Gall FP (1994) Chirurgische Standards beim Rektumkarzinom. Chirurg 65: 593–603
Köckerling F, Reymond MA, Schneider C, Hohenberger W (1997) Fehler und Gefahren in der onkologischen laparoskopischen Chirurgie. Chirurg 68: 215–224
Köhler L, Eypasch E, Paul A, Troidl H (1997) Myths in management of colorectal malignancy. Br J Surg 84: 248–251
Kähne CH, Schöffski P, Wilke H et al. (1998) Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: Results ofa randomized trial in patients with advanced colorectal cancer.) Clin Oncol 16: 418–426
Konings E, Greenberg E (1998) Antioxidant supplements and colorectal cancer. Nutrition 14: 245–247
Konsensus der CAO, A10 and ARO zur adjuvanten Therapie bei Kolon- and Rektumkarzinom vom 13.3.94.Onkologie 17:291–293
Korinek V, Barker N, Morin PJ et al. (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC -/- colon carcinoma. Science 275: 1784–1787
Kornbluth A, Sachar DB (1997) Ulcerative colitis practice guidelines in adults. Am J Gastroenterol 92: 204–211
Kotanagi HF, Shibata Y (1993) The size of regional lymph nodes does not correlate with the presence or absence of metastasis in lymph nodes in rectal cancer.) Surg Oncol 54: 252–254
Kritchevsky D (1995) Epidemiology of fibre, resistant starch and colorectal cancer. EurJ Cancer Prey 4: 345–352
Kromborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O (1996) Randomised study of screening for colorectal cancer with faecal-occult blood test. Lancet 348: 1467–1471
KrookJE, Moertel CG, Gunderson LL et al. (1991) Effective surgical adjuvant therapy for high-risk rectal carcinoma. New Engl J Med 324: 709715
Kurtz RC, Sternberg S, Miller H, de Cosse J (1987) Upper gastrointestinal neoplasia in familial polyposis. Dig Dis Sci 32: 459–465
La Vecchia C, Franceschi (1991) Reproductive factors and colorectal cancer. Cancer Causes Control 2: 193–200
Lacy AM, Garcia-Valdecasas JC, Delgado S, Castells A, Taura P, Pig JM, Visa J (2002) Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet 359: 2224–2229
Lamade W, Glomgitza G, Demiris AM et al. (1999) Virtuelle Operationsplanung in der Leberchirurgie.Chirurg 70: 239–245
Lane DP (1992) Cancer. P53, guardian of the genome. Nature 358: 15–16
Laurie JA, Moertel CG, Fleming TR et al., for the North Central CancerTreatment Group and the Mayo Clinic (1989) Surgical adjuvant therapy of large-bowel carcinoma:an evaluation of levamisole and the combination of levamisole and fluorouracil.J Clin Oncol 7: 1447–1456
Leather AJM, Gallegos NC, Kocjan G et al. (1993) Detection and enumeration of circulating tumor cells in colorectal cancer. Br J Surg 80: 777–780
Leather AJM, Kocjan G, Savage F et al. (1994) Detection of free malignant cells in the peritoneal cavity before and after resection of colorectal cancer. Dis Colon Rectum 37: 814–819
Lehnert T, Knaebel HP, Dück M, Bülzebruck H, Herfarth C (1999) Sequential hepatic and pulmonary resections for metastatic colorectal cancer. Br J Surg 86: 241–243
Lehnert Th, Herfarth Ch (1996) Grundlagen and Wert der Lymphadenektomie beim colorectalen Carcinom.Chirurg 67: 889–899
Leppert M, Dobbs M, Scambler Petal. (1987) The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 238: 1411–1413
Levine AJ, Momand J, Finlay CA (1991)The p53 tumor suppressor gene. Nature 351: 453–456
Limberg B (1992) Diagnosis and staging of colonic tumors by conventional abdominal sonography as compared with hydrocolonic sonography. N Engl J Med 327: 65–69
Lindemann F, Schlimock G, Dirschedl P, Witte J, Riethmüller G (1992) Prognostic significance of micrometastatic tumor cells in bone marrow of colorectal cancer patients. Lancet 340: 685–689
Link KH, Kreuser ED, Safi F, Ullrich J, Schalhorn A, Schmoll E, Beger HG (1993) Die intraarterielle Chemotherapie mit 5-FU and Folinsäure im Therapiekonzept bei nicht resektablen kolorektalen Lebermetastasen.Tumordiagn Ther 14: 224–231
Little JM, Hollands M (1987) Hepatic resection for colorectal metastases-Selection of cases and determinants of success. Aust N Z J Surg 57: 355–359
Liu FB, Nicolaides NC, Markowitz S et al. (1995) Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genetics 9: 48–55
Lorenz M, Hottenrott C, Maier P, Reimann M, Inglis R, Encke A (1992) Continuous regional treatment with fluoropyrimidines for metastases from colorectal carcinomas: influence of modulatiopn with leucovorin. Sem Oncol 19: [Suppl 3]: 163–170
Lorenz M, Müller HH, for the German Cooperative Group on Liver Metastases (2000) Randomized multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.J Clin Oncol 18: 243–254
Lothian and Borders health board (1995) Lothian and Borders large bowel cancer project: immediate outcome after surgery. Br J Surg 82: 888–890
Lynch HT, Lynch J (1995) Genetics, natural history, surveillance management and gene mapping in the Lynch syndrome. Pathol Biol Paris 43: 151–158
Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch PM, Cavalieri RJ, Boland CR (1993) Genetics, natural history, tumor spectrum and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104: 1535–1549
MacFarlane JK, Ryall RDH, Heald FU (1993) Mesorectal excision for rectal cancer. Lancet 341: 457–460
Machi J, Isomoto H, Kurohiji T, et al. (1991) Accuracy of intraoperative ultrasonography in diagnosing liver metastases from colorectal cancer: evaluation with postoperative follow up results. World J Surg 15: 551–557
Machover D, Goldschmidt E, Chollet P et al. (1986) Treatment of advanced colorectal and gastric adenocarcinoma with 5-fluorouracil and high-dose folinic acid.J Clin Oncol 4: 685–696
Mäkelä JT, Laitinen SO, Kairaluoma MI (1995) Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 130: 1062–1067
Malassagne B, Valleur P, Serra J, Sarnacki S, Galian A, Hoang C, Hautefeuille P (1993) Relationship of apical lymph node involvement to survival in resected colon carcinoma. Dis Colon Rectum 36: 645–653
Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schumann LM, Ederer F (1993) Reducing mortality from colorectal cancer by screening for faecal occult blood. N Engl J Med 328: 1365–1371
MarescauxJ, ClementJM, TassettiVetal.(1998)Virtual reality applied to hepatic surgery simulation:the next revolution. Ann Surg 228: 627–634
Martinez-Lopez E, Abad A, Monzo M et al. (1998) Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal carcinoma.Gastroenterology 114: 1180–1187
Mason AY (1975) Malignant tumors of the rectum: local excision.Clin Gastroenterol 4: 582–593
Matsuhashi N, Nakajima A, Fukushima Y, Yazaki Y, Oka T (1997) Effects of sulindac on sporadic colorectal adenomatous polyps. Gut 40: 344349
McArdle CS, Hole D, Hansel) D, Blumgart LH, Wood CB (1990) Prospective study of colorectal cancer in the West Scotland.10 year follow up. Br J Surg 77: 280–282
Mecklin J-P, Järvinen H (1993) Treatment and follow up strategies in hereditary nonpolyposis colorectal carcinoma. Dis Colon Rectum 36: 927–929
Mentges B, Bueß G, Effinger G, Manncke K, Becker HD (1996) Die lokale Therapie des Rectumcarcinoms.Chirurg 67: 133–138
Merkle NM, Vogt-Moykopf 1 (1989) Chirurgische Therapie von Lungenmetastasen. In: Rothmund (Hrsg) Metastasenchirurgie.Thieme, Stuttgart New York
Meta-Analysis Group in Cancer (1996) Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer.) Natl Cancer Inst 88: 252–258
Meyenberger C, Huch Böni RA, Bertschinger P, Zala GF, Klotz HP, Krestin GP (1995) Endoscopic ultrasound and endorectal magnetic resonance imaging: a prospective comparative study for preoperative staging and follow-up of rectal cancer. Endoscopy 27: 469–479
Miller AB, Howe GR, Jain M, Craib KJ, Harrison L (1983) Food items and food groups as risk factors in a case-control study of diet and colo-rectal cancer. Int J Cancer 32: 155–161
Minsky BD (1993) Clinical experience with local excision and postoperative radiation therapy for rectal cancer. Dis Colon Rectum 36: 405–409
Minsky BD, Cohen AM, Kemeny N et al. (1992) Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high dose leucovorine chemotherapy.) Clin Oncol 10: 79–84
Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Saltz L, Frankel J (1993) The efficacy of preoperative 5-fluorouracil, high-dose leucovorine, and sequential radiation therapy for unresectable rectal cancer. Cancer 71: 3486–3492
Moertel CG, Fleming TR, Macdonald JS et al (1995) Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage Ill colon carcinoma:afinal report. Inn Intern Med 122: 321–326
Moertel CG, Fleming TR, Macdonald JS et al. (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. New Engl J Med 322: 352–358
Moertel CG, Fleming TR, MacDonald JS, Haller DG, Laurie JA, Tangen C (1993) An evaluation of the carcinoembryonic antigen ( CEA) test for monitoring patients with resected colon cancer. JAMA 270: 943–947
Moertel CG, Fleming TR, Macdonald JS et al. (1 995) Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes’ B2 colon cancer.) Clin Oncol 13: 2936–2943
Mohiuddin M, Lingareddy V, Marks G (1994) Long-term results of„selective sandwich” adjunctive radiotherapy for cancer of the rectum.Am J Clin Oncol 17: 264–268
Moller H, Mellemgaard A, Lindwig K, Olsen JH (1994) Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 30A: 344–350
Moorehead RJ, Mc Kelvey STD (1989) Cholecystectomy and colorectal can- cer. Br J Surg 76: 250–253
Morikawa E, Yasutomi M, Shindou K et al. (1994) Distribution of metastatic lymph nodes in colorectal cancer by the modified clearing method. Dis Colon Rectum 37: 219–223
Morson B (1974) The polyp-cancer sequence in the large bowel. Proc Roy Soc Med 67: 451–457
Möslein G, Kadmon M, Fried! W, Herfarth Ch (1995) Restaurative Proktocolektomie mit ileoanalem J-Pouch bei symptomatischen Kindern mit familiärer adenomatöser Polyposis coli ( FAP ). Chirurg 66: 612–618
Müller P, Weckermann D, RiethmüllerG, SchlimokG (1996) Detection ofgenetic alterations in micrometastatic cells in bone marrow of cancer patients by fluorescence in situ hybridization. Cancer Genet Cytogenet 88: 8–16
Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P (1995) Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli ( APC) tumor-suppressor gene. Proc Natl Acad Sci USA 92: 3046–3050
Muto T, Bussey JH, Morson BC (1975) The evolution of cancer of the colon and rectum. Cancer 36: 2251–2270
Nakfoor BM, Willet CG, Shellito PC, Kaufman DS, Daly WJ (1998) The impact of 5-fluorouracil and intraoperative electron beam radiation therapy on the outcome of patients with locally advanced rectal and rectosigmoid cancer. Ann Surg 228: 194–200
Nelson RL, Davis FG, Sutter E, Kikendall JW, Sobin LH, Milner JA, Bowen PE (1995)Serum selenium and colonic neoplastic risk. Dis Colon Rectum 38: 1306–1310
Neugut AI, Lautenbach E, Abi-Rached B, Forde KA (1996) Incidence of adenomas after curative resection for colorectal cancer. Am J Gastroenterol 91: 2096–2098
Neuhaus H (1998) Vorsorge zur Prävention oder Früherkennung des kolorektalen Karzinoms. Dt. Ärzteblatt 95: A-530–537
Newland RC, Chapuis PH, Smyth EJ (1987)The prognostic value of substaging colorectal carcinoma: a prospective study of 1117 cases with standardized pathology. Cancer 60: 852–857
Newland RC, Dent OF, Lyttle MNB, Chapuis PH, Bokey EL (1994) Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. Cancer 73: 2076–2082
Nicolaides NC, Papadopoulos N, Liu Bet aí. (1994) Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371: 75–80
Nigro ND, Bull AW (1987) Prospects for the prevention of colorectal cancer. Dis Colon Rectum 30: 751–754
NIH Consensus Conference (1990) Adjuvant therapy for patients with colon and rectal cancer.JAMA 264: 1444–1450
Brien MJ, Winawer SJ, Zauber AG et al. (1990) The national polyp study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 98: 371–379
Connell MJ, Martenson JA, Wieand HS et al. (1994) Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery.N Engl J Med 331: 502–507
Ohlsson B, Breland U, Ekberg H, Graffner H, Tranberg KG (1995) Follow-up after curative surgery for colorectal cancer. Randomized comparison with no follow-up. Dis Colon Rectum 38: 619–626
Ohman U (1982) Prognosis in patients with obstructing colorectal carcinoma. Am J Surg 143: 742–747
Okuno M, IkeharaT, Nagayama M, KatoY, Yui S, Umeyama K (1996) Mucinous colorectal carcinoma: clinical pathology and prognosis. Ann Surg Oncol 3: 344–348
Oldhafer KJ, Högemann D, Stamm G, Raab R, Peitgen HO, Galanski M (1999) Dreidimensionale (3-D) Visualisierung der Leber zur Planung erweiterter Leberresektionen. Chirurg 70: 233–238
Opelz G, Mickey MR, Sengar DPS, Terasaki PI (1973)Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 5: 253–259
Oshima M, Dinchuk JE, Kargman SL et al. (1996) Supression of intestinal polyposis in APC delta 716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87: 803–809
Otto G, Richter GM, Herfarth C (1997) Bedeutung bildgebender Verfahren für die chirurgische Indikationsstellung bei soliden Lebertumoren. Chirurg 68: 334–345
Pagana TJ, Ledesma EJ, Mittelman A, Nava HR (1984) The use of colonoscopy in the study of synchronous colorectal neoplasms. Cancer53: 356–359
Pahlman L, Glimelius B (1990) Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Ann Surg 211: 187–195
Pantel K, Braun S, SchlimokG, RiethmüllerG (1993b) Micrometastatictumor cells in bone marrow in colorectal cancer. Lancet 341: 501
Pantel K, Dickmanns A, Zippelius A et al. (1995) Establishment of micrometastatic carcinoma cell lines: a novel source of tumor cell vaccines.J Natl Cancer Inst 87: 1162–1168
Pantel K, Schlimok G, Braun S Kutter D, Schaller G, Funke I, Izbicki J, Riethmüller G (1993a) Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells.J Natl Cancer Inst 85: 1419–1424
Pantel K, Schlimok G, Kutter D et al. (1991) Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells Cancer Res 51: 4712–4715
Papillon J (1975) Intracavitary irradiation of early rectal cancer for cure. A series of 186 cases. Cancer 36: 696–701
Pass HI, Donington JS (1997) Metastatic cancer to the lung. In: De Vita VT, Hellman S, Rosenberg SA (Hrsg) Cancer principles and practice of oncology, 5th edn. Lippincott-Raven, Philadelphia, pp 2546–2547
Passman MA, Pommier RF, Vetto JT (1996) Synchronous colon primaries have the same prognosis as solitary colon cancers. Dis Colon Cancer 39: 329–334
Patt YZ, Podoloff DA, Curley S, Kasi L, Smith C (1994) Technetium 99m-labeles IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging for occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels.J Clin Oncol 12: 489–495
Peltomäki P, Aaltonen LA, Sistonen P et al. (1993) Genetic mapping ofa lo- cus predisposing to human colorectal cancer. Science 260: 810–812
Petrelli N, Douglass HO Jr., Herrera L et al. (1989) The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase Ill trial.J Clin Oncol 7: 1419–1426
Phillips RK, Hittinger R, Blesovski L, FryJS, Fielding LP(1984) Local recurrence for large bowel cancer:I.The overall picture. Br J Surg 71: 12–16
Pihl E, Hughes ES, McDermott FT, Milne BJ, Korner JM, Prince AB (1980) Carcinoma of the colon.Cancer specific long-term survival.A series of 615 patients treated by one surgeon. Ann Surg 192: 114–114
Pool EH, Dunlop GR (1934) Cancer cells in the bloodstream. Am J Surg 21: 99–102
Poon MA, O’Connell MJ, Moertel CG et al. (1989) Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.J Clin Oncol 7: 1407–1418
Poon MA, O’Connell MJ, Wieand HS et al. (1991) Biochemical modulation of fluorouracil with leucovorin: Confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol 9: 1967–1972
Porter GA, Soskolne CL, Yakimets WW, Newman SC (1998) Surgeon-related factors and outcome in rectal cancer. Ann Surg 227: 157–167
Poulin EC, Mamazza J, Schlachta CM, Gregoire R, Roy N (1999) Laparoscopic resection does not adversely affest survival curves in patients undergoing surgery for colorectal adenocarcinoms. Ann Surg 229: 487–492
Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN Vogelstein B, Kinzler KW (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359: 235–237
Pricolo VE, Finkelstein SD, Hansen K, Cole BF, Bland KI (1997) Mutated p53 gene is an independent adverse predictor of survivalo in colon carcinoma.Arch Surg 132: 371–374
Punt CJA, Nagy A, Douillard JY et al. (2001) Edrecolomab (17–1A antibody) alone or in combination with 5-fluorouracil based chemotherapy in the adjuvant treatment of stage Ill colon cancer; results of a phase Ill study. ASCO Proc 20
Queißer W (1999) Aktueller Stand der adjuvanten Chemo- and Immuntherapie des Kolonkarzinoms.Onkologe 5: 30–34
Quirke P, Durdey P, Dixon MF, Williams NS (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumor spread and surgical resection. Lancet II: 996–999
Rafaelsen SR, Kronborg O, Larsen C, Fenger C (1995) Intraoperative ultrasonography in detection of hepatic metastases from colorectal cancer. Dis Colon Rectum 38: 355–360
Ramirez JM, Mortenden NJMcC, Takeuchi N, Smilgin Humphreys MM (1994) Endoluminal ultrasound in the follow up of patients with rectal cancer. Br J Surg 81: 692–694
Read TE, Read JD, Butterly LF (1997) Importance of adenomas 5 mm or less in diameter that are detected by sigmoidoscopy. N Engl J Med 336: 8–12
Reilly JC, Rusin LC, Theuerkauf H (1982) Colonoscopy: its role in cancer of the colon and rectum. Dis Colon Rectum 25: 528–532
Rex DK, Cutler CS, Lemmel GT, Kaster S, Buckley JS (1997) Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 112: 17–23
Rheinbach DH, Mc Gregor JR, Murray GD, O’Dwyer PJ (1994) Effect of surgeon’s speciality interest on the type of resection performed for colorectal cancer. Dis Colon Rectum 37: 1020–1023
Richter GM, Theobald I, Roeren T, Wunsch C, Lehnert T, Kauffmann GW (1996) Die Spiral-CT-Portographie in der präoperativen Diagnostik von Lebermetastasen. Chirurg 67: 630–636
Rickert RR, Averbach O, Garfinkel L, Hammond EC, Frasca JM (1979) Adenomatous lesions of the large bowel: an autopsy survery. Cancer 43: 1847–1857
Rider JA, Kirsner JB, Moeller HC (1959) Polyps of the colon and rectum.)AMA 170: 633–637
Riethmüller G, Holz E, Schlimok G et al. (1998) Monoclonal antibody therapy for resected Duke’s C colorectal cancer: Seven-year outcome of a multicenter randomized trial.) Clin Oncol 16: 1788–1794
Riethmüller G, Schneider-Gädicke E, Schlimok G et al. (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes’C colorectal carcinoma. Lancet 343: 1177–1183
Rifkin MD, Rosato FE, Branch HM, Foster J, Yang SL, Barbot DJ, Marks GJ (1987) Intraoperative ultrasound of the liver. Ann Surg 205: 466–472
Roberts S, Jonasson O, Long L (1961) Clinical significance of cancer cells in the circulating blood: two to five year survival. Ann Surg 154: 362–370
Rodriguez-Bigas MA, Lee PHU, O’Malley L, Weber TK, Suh O, Anderson GR, Petrelli NJ (1996) Establishment of a hereditary nonpolyposis colorectal cancer registry. Dis Colon Rectum 39: 649–653
Rodriguez-Bigas MA, Vasen HF, Pekka-Mecklin J et al. (1997) Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International Collaborative Group on HNPCC. Ann Surg 225: 202–207
Rollinson PD, Dundas SAC (1984) Adenocarcinoma of the sigmoid colon seeding into preexisting fistula-in-ano. Br J Surg 71: 664–665
Romano G, Rotondano G, Esposito P (1995) Endoluminal ultrasonography in the diagnosis of locally recurrent rectal cancer. Endoscopy 27: 59
Rosato FE, Shelly WB, Fitts WT, Miller LD (1969) Non-metastatic cutaneous manifestations of cancer of the colon. Am J Surg 117: 277–281
Rosen HR, Schiessel R (1996) Die vordere Rektumresektion. Chirurg 67: 99–109
Rougier P, Bugat R, Douillard JY et al. (1997) Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy. J Clin Oncol 15: 251–260
Rozen P, Fireman Z, Fine N, Wax Y, Ron E (1989) Oral calcium suppresses increased rectal epithelial proliferation of persons at risk for colorectal cancer. Gut 30: 650–655
Rubinfeld B, Albert I, Porfiri E, Munemitsu S, Polakis P (1997) Loss of betacatenin regulation by the APC tumor supressor protein correlates with loss of structure due to common somatic mutations of the gene. Cancer Res 57: 4626–4630
Runkel NS, Schlag P, Schwarz V, Herfarth C (1991) Outcome after emergency surgery for cancer of the large intestine. Br J Surg 78: 183–188
Saltz LB, Cox JV, Blanke C et al. (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. New Engl J Med 343: 905–914
Saltz LB, Cox JV, Blanke C et al. (2000) Irinotecan plus fluorouracil and leu- covorin for metastatic colorectal cancer. N Engl J Med 343: 905–914
Sanfilippo F, Thacker L, Vaughn WK (1990) Living-donor renal transplantation in SEOPF: the impact of histocompatibility, transfusions and cyclosporine on outcome.Transplantation 49: 25–29
Saß NL, Koop H (1998) Aktuelle Aspekte endoskopischer Diagnostik und endoluminaler Behandlung kolorektalerTumoren.Onkologe 4 [Suppl 1]: S8 - S14
Saß NL, Koop H (1999) Kolonkarzinom: Früherkennung und Nachsorge. Onkologe 5: 15–23
Schalhorn A (1999) Neue Substanzen in der Therapie kolorektaler Karzinome. Aktuelle Onkologie 106: 99–113
Schalhorn A (2000) Oxaliplatin–ein neues Zytostatikum zur Behandlung kolorektaler Karzinome. Arzneimittelther 18: 198–202
Schalhorn A, Jauch KW (1999) Kolorektale Karzinome. In: Wilmanns W, Huhn D, Wilms K (Hrsg) Internistische Onkologie, 2. Aufl. Thieme, Stuttgart New York
Schalhorn A, Kühl M (1992) Clinical pharmacokinetics of fluorouracil and folinic acid. Sem Oncol 19 [Suppl 31: 82–92
Schalhorn A, Kühl M (1995) Pharmakologie der regionalen Chemotherapie kolorektaler Lebermetastasen. Zentralbl Chir 120: 764–768
Schalhorn A, Lorenz M, Schmoll E: Regionale Chemotherapie von Lebermetastasen. In: Schmoll HJ, Höffken K, Possinger K (Hrsg) Kompendium internistische Onkologie, Bd 2, 3 Aufl. Springer, Berlin Heidelberg New York Tokyo, S 2425–2439
Schattuck-Brandt RL, DuBois RN (1999) The molecular basis of colorectal carcinogenesis.Curr Opin Gastroenterology 15: 3–8
Scheithauer W, Konek GV, Raderer M et al. (1999) Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer.) Clin Oncol 17: 902–906
Scheithauer W, Kornek G (1995) Früherkennung des kolorektalen Karzinoms. Onkologie 15: 36–40
Scheithauer W, Rosen H, Kornek GV, Sebesta C, Depisch D (1993) Randomized comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer Br Med J 306: 752–755
Schlag P, Hohenberger P, Herfarth Ch (1990) Resection of liver metastases in colorectal cancer-Competitive analysis of treatment results in synchronous versus metachronous metastases.EurJ Surg Oncol 16: 360–365
Schlag PM (1998) Kolorektaler Rezidivtumor. Onkologe 4: 757–760
Schlag PM, Rau B (1997) Chirurgische and multimodale Therapie des Rek- tumkarzinomrezidivs. Langenbecks Arch Chir Suppl Il: 717–719
Schlimok G, Funke I, Bock B, Schweiberer B, WitteJ, RiethmüllerG (1990) Epithelial tumor cells in bone marrow of patients with colorectal cancer: Immunocytochemical detection, phenotypic characterization, and prognostic significance.) Clin Oncol 8: 831–837
Schlimok G, Funke I, Holzmann B et al. (1987) Micrometastatic cancer cells in bone marrow:In vitro detection with anti-cytokeratin and in vivo labeling with anti-17–1A monoclonal antibodies. Proc Natl Acad Sci USA 84: 8672–8776
Schmid M, HaafT, Grunert D (1984) 5-Azacytidine-induced undercondensation in human chromosomes. Hum Genet 67: 257–263
Schmoll HJ, Köhne CH, Lorenz M et al. (2000) Weekly 24h infusion of high-dose 5-fluorouracil with or without folinic acid versus bolus 5-FU/FA in advanced colorectal cancer: a randomized phase Ill study of the EORTC GITCCG and the AIO. ASCO Proc 19: #935
Schöffski P, Vanhoefer U, Kirchner H et al. (2000) Phase II study of irinotecan as second line chemotherapy in metastatic colorectal cancer after prior exposure to infusional 5-FU-based chemotherapy. ASCO Proc 19: #1155
Schumpelick V, Braun J (1996) Die intersphinctäre Rectumresektion mit radikulärer Mesorectumexcision and coloanaler Anastomose.Chirurg 67: 110–120
Selby JV, Friedmann GD, Quesenberry CP, Weiss NS (1992) A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326: 653–657
Seow-Choen F, Goh HS (1995) Prospective randomized trial comparing J colonic pouchanal anastomosis and straight coloanal reconstrucion. Br J Surg 82: 608–610
Shibata D, Reale MA, Lavin Petal. (1996) The DCC protein and prognosis in colorectal cancer. N Engl J Med 335: 1727–1732
Shida H, Ban K, Matsumoto M, Masuda K, Imanari T, Machida T, Yamamato T (1992) Prognostic significance of location of lymph node metastases in colorectal cancer. Dis Colon Rectum 35: 1046–1050
Shoemaker D, Black R, Giles L, Toouli 1 (1998) Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients.Gastroenterology 114: 7–14
Silverman AL, Park JG, Hamilton SR, Gazdar AF, LukGD, Baylin SB (1989) Abnormal methylation of the calcitonin gene in human colonic neoplasms. Cancer Res 49: 3468–3473
Slater GI, Haber RH, Aufses AH (1984) Changing distribution of carcinomas of the colon and rectum. Surg Gyneol Obstet 158: 216–218
Slattery ML, Sorenson AW, Ford MH (1988) Dietary calcium intake as mitigating factor in colon cancer. Am J Epidemiol 128: 504–514
Slisow W, Marx G, Krüger J (1992) Zur iatrogenen Diagnoseverzögerung beim Rektumkarzinom. Zentralbl Chir 117: 73–76
Soeth E, Roder C, Juhl H, Krüger U, Kremer B, Kalthoff H (1996) The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease.lnt J Cancer 69: 278–282
Soeth E, Vogel I, Roder C et al. (1997) Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR.Cancer Res 57: 3106–3110
Soyer P, Bluemke DA, Hruban RH, Sitzmann JV, Fichman EK (1994) Hepatic metastases from colorectal cancer: detection and false positive findings with helical CT during arterial portography.Radiology 193: 71–74
Sparks AB, Morin PJ, Vogelstein B, Kinzler KW (1998) Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58: 1130–1134
Spiegelmann D, Wegman DH (1985) Occupational-related risks for colorectal cancer.) Natl Cancer Inst 75: 813–821
St John DJ, Young GP, Alexeyeff MA, Deacon MC, Cuthbertson AM, Macrae FA, Penfold JC (1993) Evaluation of new occult blood tests for detection of colorectal neoplasia.Gastroenterology 104: 1661–1668
St.John DJ, Mc Dermott FT, Hopper JL, Debney EA, Johnson WR, Hughes ES (1993) Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med 118: 785–790
Stafford KL, Kovalik PJ, Cross GH (1981) Review of colorectal carcinoma in patients under age 40 years. Am J Surg 142: 767–771
Stapel A, Franke U, Putzki H (1992) Die Bedeutung von CEA and CA 19–9 für die Nachsorge kurativ resezierter kolorektaler Karzinome. Zentralbl Chir 117: 77–80
Steinberg SM, Barwick KW, Stablein DM (1986) Importance of tumor pathology and morphology in patients with surgical resected colon cancer.Cancer 58: 1340–1345
Stephens WR, Rbiz P (1989) Primary linitis plastica carcinoma of the colon and rectum. Mod Pathol 2: 265–269
Stern J, Kienle P (1996) Notwendige präoperative Funktionsdiagnostik zur tiefen anterioren Rektumresektion.Chirurg 67: 129–132
Stewart J, Evan G, Watson J, Sikora K (1986) Detection of the c-myc onco- gene product in colonic polyps and carcinomas. Br J Cancer 53: 1–6
StrumerT, Glyn R), Lee I, Manson JE, Buring JE, Hennekens CH (1998) Aspirin use and colorectal cancer: post-trial follow-up data from the physicians health study. Ann Intern Med 128: 713–720
Sugarbaker PH, Corlew S (1982) Influence of surgical techniques on survival of patients with colorectal cancer. Dis Colon Rectum 25: 545–557
Swedish Rectal Cancer Trial (1997) Improved survival with preoperative ra- diotherapy in resectable rectal cancer. N Engl J Med 336: 980–987
Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF, Takeo MM (1998) Intestinal tumorigenesis in compound mutant mice of both DPC4(Smad4) and APC genes. Cell 92: 645–656
Takeuchi H, Toda T, Nagasaki S, Kawano T, Minamisono Y, Maehara Y, Sugimachi K (1997) Synchronous multiple colorectal adenomas. J Surg Oncol 64: 304–307
Taylor MC, Pounder D, Ali-Ridha NH, Bodurtha A, McMullin EC (1988) Prognostic factors in colorectal carcinoma of young patients.Can J Surg 31: 150–153
Tempero M, Brand R, Holderman K, Matamoros A (1995) New imaging techniques in colorectal cancer.Semin Oncol 22: 448–471
Thiagalingam S, Lengauer C, Leach FS et al. (199) Evaluation of candidate tumor suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 13: 343–346
Thibodeau SN, Bren G, Schaid D (1993) Microsatellite instability in cancer of the proximal colon. Science 260: 816–819
Thibodeau SN, French AJ, Cunningham JM et aí. (1998) Microsatellite instability in colorectal cancer:different mutator phenotypes and the principal involvement of hMLH1.Cancer Res 58: 1713–1718
Thune I, Lund E (1996) Physical activity and risk of colorectal cancer in men and women. Br J Cancer 73: 1134–1140
Thun MJ, Namboodiri MM, Health CW (1991) Aspirin use and reduced risk of fatal colon cancer. N Eng J Med 325: 1593–1596
Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW (1993) Aspirin use and risk of fatal cancer.Cancer Res 53: 1322–1327
Tierney RP, Ballantyne GH, Modlin IM (1990) The adenoma to carcinoma sequence.Surg Gynecol Obstet 171: 81–94
Tong D, Russel AH, Dawson LE, Wisbeck W (1983) Second laparotomy for proximal colon cancer: sites of recurrence and implications for adjuvant therapy. Am J Surg 145: 382–385
Trock B, Lanza E, Greenwals P (1990) Dietaryfiber, vegetables and colon cancer: Critical review and meta-analysis of the epidemiological evidence.J Nat Cancer Inst 82: 650–661
Turnbull RB, Kyle K, Watson FR, Spratt J (1967) Cancer of the colon:The influence of the no-touch isolation technic on survival rates. Ann Surg 166: 420–425
Umpleby HC, Williamson RCN (1984a) Carcinoma of the large bowel in the first four decades. Br J Surg 71: 272–277
Umpleby HC, Williamson RCN (1984b) Survival in acute obstructing colorectal carcinoma. Dis Colon Rectum 27: 299–304
Umpleby HC, Ranson DL, Willianson RCN (1985) Peculiarities of mucinous colorectal carcinoma. Br J Surg 72: 715–718
Van Cutsem E, Bajetta E, Niederle N et aí. (1998) A phase Ill multicenter randomized trial comparing CPT-11 to infusional 5-FU regimen in patients with advanced colorectal cancer after 5-FU failure.ASCO Proc 17, p 256a (#984)
Van Cutsem E, Findlay M, Osterwalder B et al. (2000) Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study.J Clin Oncol 18: 1337–1345
Van Cutsem E, Szanto J, Roth A, et al. (1999) Evaluation of the addition of oxaliplatin to the same Mayo or German 5FU regimen in advanced refractory colorectal cancer.ASCO Proc 18:#900
Van der Meer R, Welberg JWM, Kuipers F et al. (1990) Effects of supplemental dietary calcium on the intestinal association of calcium, phosphate and bile acid. Gastroenterology 99: 1653–1659
Vemulapalli R, Lance P (1994) Cancer surveillance in ulcerative colitis:more of the same or progress. Gastroenterology 107: 1196–1199
Vining DJ (1996) Virtual endoscopy: is it reality? Radiology 200: 30–31
Vogelstein B, Fearon ER, Hamilton SR et al. (1988) Genetic alterations during colorectal-tumor development. N Eng J Med 319: 525–532
Wagner JS, Adson MA, van Herrden JA, Adson MN, Ilstrup DM (1984) The natural history of hepatic metastases from colorectal cancer. Ann Surg 199: 502–508
Wanebo HJ, Koness RJ, Verzeridis MP, Cohen SI, Wrobleski DE (1994) Pelvic resection of recurrent rectal cancer. Ann Surg 220: 586–595
Wang J, Sun L, Myeroff L et al. (1995) Demonstration that mutation of the type Il transforming growth factor beta receptor inactivates it’s tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem 270: 22044–22049
Wang L, Patel U, Gosh L, Chn HC, Banerjee 5 (1993) Mutation in the nm32 gene is associated with metastasis in colorectal cancer.Cancer Res 53: 717–720
Wargovich MJ (1988) New dietary anticarcinogens and prevention of gastrointestinal cancer. Dis Colon Rectum 31: 72–75
Wargovich MJ, Baer AR (1989) Basic and clinical investigations of dietary calcium in the prevention of colorectal cancer. Prey Med 18: 672–679
Wargovich MJ, Lynch PM, Levin B (1991) Modulating effects of calcium in animal models of colon carcinogeneses and short-term studies in subjects at increased risk for colon cancer. Am J Clin Nutr 54: 2025–2055
Wassermann E, Cuvier C, Lokiec F et al. (1999) Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: results of two independent phase I studies with pharmacokinetics.J Clin Oncol 17: 1751–1759
Wassner A, Heidemann E (1996) Levamisole and 5-fluorouracil as an adjuvant therapy for patients after curative resection of colon carcinoma Dukes’ stage C ( TNM Ill ): More disadvantages than advantages. Onkologie 19: 140–145
Watson P, Lin KM, Rodriguez-Bigas MA, Smyrk Z (1998) Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members.Cancer 83: 259–266
Weh HJ, Wilke HJ, Dierlamm J et al. (1994) Weekly therapy with folinic acid and high-dose 5-fluorouracil 24-hour infusion in pretreated patients with metastatic colorectal carcinoma. A multicenter study by the Association of Medical Oncology of the German Cancer Society ( AIO ). Annals Oncol 5: 233–237
Weh HJ, Zschaber R, Baumann D et al. (1998) A randomised phase Ill study comparing weekly folinic acid (FA) and high-dose 5-fluorouracil (5-FU) with monthly 5-FU/FA d1–5 in untreated patients with metastatic colorectal carcinoma. Onkologie 21: 403–407
Weiss L, Grundmann E, TorhorstJ et al. (1986) Haematogenous metastastic patterns in colonic carcinoma:an analysis of 1541 necropsies.J Pathol 150: 195–203
Weitz J, Kienle P, Lacroix J, Willeke F, Lehnert Th, Herfarth Ch, von Knebel Doeberitz M (1997) Detektion hämatogenerTumorzelldissemination kolorektaler Karzinome. Langenbecks Arch Chir Suppl 1: 733–336
Weitz J, Kienle P, Lacroix J et al. (1998) Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Clin Cancer Res 4: 343–348
Weitz J, Kienle P, Magener A et aí. (1999) Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow. Clin Cancer Res 5: 1830–1836
Weitz J, Koch M, Lehnert Th, Herfarth Ch, von Knebel Doeberitz M (2000) Nachweis isolierter disseminierter Tumorzellen kolorektaler Karzinome in Lymphknoten.Chirurg 71: 410–416
Welch JP, Donaldson GA (1979)The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 189: 496–502
Westhues H (1934) Die pathologisch-anatomischen Grundlagen der Chirurgie des Rektumkarzinomes.Thieme, Leipzig
White H, Griffiths JD, Salisbury AJ (1976) Circulating malignant cells and fibrinolysis during resection of colorectal cancer. Proc R Soc Med 69: 467–469
Wiggers T, Arends JW, Volovics A (1988) Regression analysis of prognostic factors in colorectal cancer after curative resection. Dis Colon Rectum 31: 33–41
Wiggers T, Jeekel J, Arends JW et al. (1994) No-touch isolation techniques in colon cancer: a controlled prospective trial. Br J Surg 75: 409–415
Willet WC (1989) The search for the causes of breast and colon cancer. Nature 338: 389–394
Willet WC (1994) Diet and health: what should we eat? Science 264: 532–537
Willet WC, Stampfer MJ, Colditz GA, Rosner BA, Speizer FE (1990) Relation of meat, food and fiber intake to the risk of colon cancer in a prospective study amongst women. N Engl J Med 323: 164–175
Winawer SJ, Fletcher RH, Miller L et al. (1997) Colorectal cancer screening: clinical guidlines and rationale. Gastroenterology 112: 594–642
Winawer SJ, Zauber AG, Gerdes Het al., and the national polyp study work-group (1996) Risk of colorectal cancer in the families of patients with adenomatous polyps. N Engl J Med 334: 82–87
Winawer SJ, Zauber AG, Ho MN et al. (1993) Prevention of colorectal cancer by colonoscopic polypectomy.The National Polyp Study Workgroup. N Engl J Med 329: 1977–1981
Winawer SJ, Zauber AG, O’Brien MJ et al., and the national polyp study group (1993a) Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med 328: 901–906
Winde G, Schmid K, Brandt B, Muller O, Osswald (1997) Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis. Dis Colon Rectum 40: 1156–1168
Wittekind Ch, Meyer HJ, Bootz F (2003) UICC:TNM-Klassifikation maligner Tumoren, 6. Aufl. Springer, Heidelberg Berlin New York
Wolmark N, Nieand HS, Rockette HE et al., other NSABP investigators (1983) The prognostic significance of tumor location and bowel obstruction in Duke’s B and C colorectal cancer: findings from the NSABP clinical trials. Ann Surg 198: 743–752
Wolmark N, Fisher B, Wieand HS et al.(1984)The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP clinical trials. Ann Surg 199: 375–382
Wolmark N, Fisher B, Wieand HS (1986)The prognostic value of the modifications of the Dukes’C class of colorectal cancer. Ann Surg 203: 115–122
Wolmark N, Rockette H, Fisher B et al. (1993) The benefit of leucovorinmodulated fluorouracil as postoperative adjuvant therapy for primary colon cancer:resultsfrom National Surgical Adjuvant Breast and Bowel Project protocol C-03.J Clin Oncol 11: 1879–1887
Wolmark N, Rockette H, Mamounas EP et al. (1996) The relative efficacy of 5-FU + leucovorin, 5-FU + levamisole, and 5-FU + leucovorin + levamisole in patients with Duke’s B and C carcinoma of the colon. ASCO Proc 15:#460, p 205
Wright CM, Dent OF, Barker M, Newland RC (2000) Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer. Br J Surg 87: 1197–1202
Wu AH, Paganini-Hill A, Ross RK, Henderson BE (1987) Alcohol physical activity and other risk factors of colorectal cancer: a prospective study. Br J Cancer 55: 687–694
Z’graggen K, Maurer CA, Birrer S, Giachino D, Kern B, Buchler MW (2001) A new surgical concept for rectal replacement after low anterior resection:the transverse coloplasty pouch. Ann Surg 234: 780–787
Zauber AG, Winawer SJ, Bond JH et al. (1997) Can surveillance intervals be lengthened following colonoscopic polypectomy? Gastoenterology 112: A50
Zhou S, Buckhaults P, Zawel L, Bunz F, Riggins G, Le Dai J, Kern SE, Kinzler KW, Vogelstein B (1998) Targeted deletion of Smad 4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells. Proc Natl Acad Sci USA 95: 2412–2416
Zirngibl H, Husemann B, Hermanek P (1990) Intraoperative spillage of tumor cells in surgery for rectal cancer. Dis Colon Rectum 33: 610–614
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Weitz, J., Schalhorn, A., Kadmon, M., Eble, M.J., Herfarth, C. (2004). Kolon- und Rektumkarzinom. In: Die Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-06670-6_38
Download citation
DOI: https://doi.org/10.1007/978-3-662-06670-6_38
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-06671-3
Online ISBN: 978-3-662-06670-6
eBook Packages: Springer Book Archive